Metformin in the prevention of preeclampsia

Phase 2

• Conditions: preeclampsia.; Pre-eclampsia

• Registration Number: IRCT20230730058975N1
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 21 August 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 160

Inclusion Criteria

age 18 to 45
informed consent
having risk factors for preeclampsia

Exclusion Criteria

underlying disease like diabetes

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Preeclampsia. Timepoint: Every two weeks from the 12th week of pregnancy. Method of measurement: history taking and physical examination.